Skip to main content
Terug
Watch Compare

Sensus Healthcare, Inc.

Datakwaliteit: 100%
SRTS
Nasdaq Manufacturing Measuring & Analyzing Instruments
€ 4,42
€ 0,00 (0,00%)
Marktkapitalisatie: 72,76 M
Prijs
€ 4,42
Marktkapitalisatie
72,76 M
Dagbereik
€ 4,25 — € 4,50
52-Weeksbereik
€ 3,03 — € 5,92
Volume
16.493
Openen € 4,44
50D / 200D Gem.
€ 4,33
1,97% above
50D / 200D Gem.
€ 4,05
9,18% above

Quick Summary

Belangrijkste Punten

Revenue grew 0,40% annually over 5 years — modest growth
Earnings declined -216,13% over the past year
Generating 332.000,0 in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 34,66%
Capital efficient — spends only 0,71% of revenue on capex

Groei

Revenue Growth (5Y)
0,40%
Onder sectorgemiddelde (1,82%)
Revenue (1Y)-34,26%
Earnings (1Y)-216,13%
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-14,95%
Boven sectorgemiddelde (-53,41%)
ROIC-15,67%
Net Margin-28,09%
Op. Margin-37,50%

Veiligheid

Debt / Equity
N/A
Current Ratio7,38
Interest Coverage-15,09

Waardering

PE (TTM)
-9,43
Onder sectorgemiddelde (-1,48)
P/B Ratio1,42
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -9,4 -1,5
P/B 1,4 1,6
ROE % -15,0 -53,4
Net Margin % -28,1 -41,5
Rev Growth 5Y % 0,4 1,8
D/E — 0,3

ETFs Holding This Stock

PRCGX PRCGX
1,03% weight
AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0,01% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -34,26% Revenue Growth (3Y) 6,12%
Earnings Growth (1Y) -216,13% Earnings Growth (3Y) N/A
Revenue Growth (5Y) 0,40% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 27,48 M Net Income (TTM) -7,72 M
ROE -14,95% ROA -13,18%
Gross Margin 43,18% Operating Margin -37,50%
Net Margin -28,09% Free Cash Flow (TTM) 332.000,0
ROIC -15,67% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 7,38
Interest Coverage -15,09 Asset Turnover 0,47
Working Capital 43,40 M Tangible Book Value 51,19 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -9,43 Forward P/E N/A
P/B Ratio 1,42 P/S Ratio 2,65
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 0,46%
Market Cap 72,76 M Enterprise Value 48,31 M
Per Share
EPS (Diluted TTM) -0,47 Revenue / Share 1,67
FCF / Share 0,02 OCF / Share 0,03
EPS CAGR (1Y) -214,63% EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,71% FCF Conversion -4,30%
SBC-Adj. FCF 68.000 Growth Momentum -34,66

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 27,48 M 41,81 M 24,41 M 44,53 M 27,04 M
Net Income -7,72 M 6,65 M 485.000,0 24,24 M 4,12 M
EPS (Diluted) -0,47 0,41 0,03 1,46 0,25
Gross Profit 11,87 M 24,43 M 14,06 M 29,63 M 16,99 M
Operating Income -10,31 M 8,09 M -382.000,0 14,83 M 4,12 M
EBITDA — — — — —
R&D Expenses 7,78 M 4,22 M 3,68 M 3,46 M 3,44 M
SG&A Expenses 7,87 M 7,15 M — — —
D&A 400.000,0 239.000,0 275.000,0 315.000,0 613.000,0
Interest Expense 683.000,0 -932.000,0 -992.000,0 2.000,0 2.000,0
Income Tax -1,91 M 2,38 M 167.000,0 3,75 M —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 53,04 M 62,17 M 53,71 M 56,74 M 32,24 M
Total Liabilities 4,94 M 6,34 M 4,87 M 8,67 M 6,23 M
Shareholders' Equity 48,10 M 55,83 M 48,84 M 48,07 M 26,02 M
Total Debt — — — — —
Cash & Equivalents 22,08 M 22,06 M 23,15 M 25,52 M 14,52 M
Current Assets 45,89 M 56,74 M 49,53 M 53,24 M 31,25 M
Current Liabilities 4,72 M 5,89 M 4,21 M 7,70 M 5,96 M